hydroxychloroquine and ganciclovir

hydroxychloroquine has been researched along with ganciclovir in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Andrei, G; De Jonghe, S; Groaz, E; Herdewijn, P; Snoeck, R; Zheng, Z	1
Blanco, J; Buzón, MJ; Carrillo, J; Clotet, B; Martínez-Picado, J; Massanella, M; Negredo, E; Pérez-Álvarez, N; Puertas, MC; Puig, J	1
Aslan Sirakaya, H; Sahiner, M; Sirakaya, E	1

Reviews

1 review(s) available for hydroxychloroquine and ganciclovir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for hydroxychloroquine and ganciclovir

Article	Year
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery. AIDS (London, England), 2012, Nov-28, Volume: 26, Issue:18 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Ganciclovir; HIV Infections; Humans; Hydroxychloroquine; Inflammation; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; Valganciclovir; Viral Load	2012

Article

Year

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.

AIDS (London, England), 2012, Nov-28, Volume: 26, Issue:18

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Ganciclovir; HIV Infections; Humans; Hydroxychloroquine; Inflammation; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; Valganciclovir; Viral Load

2012

Other Studies

3 other study(ies) available for hydroxychloroquine and ganciclovir

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Influence of 4'-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2. ACS medicinal chemistry letters, 2021, Jan-14, Volume: 12, Issue:1 Topics:	2021
A Patient With Bilateral Conjunctivitis Positive for SARS-CoV-2 RNA in a Conjunctival Sample. Cornea, 2021, Mar-01, Volume: 40, Issue:3 Topics: Administration, Ophthalmic; Administration, Oral; Adult; Antirheumatic Agents; Antiviral Agents; Conjunctiva; Conjunctivitis, Viral; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Drug Therapy, Combination; Eye Infections, Viral; Ganciclovir; Humans; Hydroxychloroquine; Intraocular Pressure; Male; Nasopharynx; Pharmaceutic Aids; Povidone; RNA, Viral; SARS-CoV-2; Slit Lamp Microscopy; Visual Acuity	2021